We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AT&T
T
$165B
| $203M | 0.44% |
13,226,238
+12,937,174
| +4,476% | +$235M |
|
|
ATVI
27
DELISTED
Activision Blizzard
ATVI
| $201M | 0.44% |
2,709,641
+1,663,416
| +159% | +$130M |
|
28
Alphabet (Google) Class A
GOOGL
$3.91T
| $199M | 0.44% |
2,079,927
-162,473
| -7% | -$18M |
|
29
Dollar General
DG
$25.9B
| $199M | 0.44% |
829,302
+596,393
| +256% | +$147M |
|
30
Agilent Technologies
A
$39.1B
| $197M | 0.43% |
1,622,511
+312,836
| +24% | +$40.2M |
|
31
Chevron
CVX
$388B
| $196M | 0.43% |
1,362,101
+1,325,834
| +3,656% | +$202M |
|
32
Broadcom
AVGO
$1.82T
| $191M | 0.42% |
4,295,950
-2,835,840
| -40% | -$145M |
|
33
Stellantis
STLA
$16.5B
| $189M | 0.41% |
15,755,514
+12,377,760
| +366% | +$166M |
|
34
Ovintiv
OVV
$17.5B
| $188M | 0.41% |
4,078,495
-445,450
| -10% | -$21.3M |
|
35
Pfizer
PFE
$140B
| $176M | 0.39% |
4,031,087
-2,172,001
| -35% | -$106M |
|
36
Costco
COST
$415B
| $172M | 0.38% |
364,345
+226,239
| +164% | +$118M |
|
37
Enphase Energy
ENPH
$4.84B
| $170M | 0.37% |
610,944
+607,989
| +20,575% | +$164M |
|
|
CMA
38
DELISTED
Comerica
CMA
| $169M | 0.37% |
2,377,028
+267,593
| +13% | +$21.1M |
|
39
Bio-Techne
TECH
$11.2B
| $165M | 0.36% |
2,325,752
+533,600
| +30% | +$46.1M |
|
40
Lamb Weston
LW
$6.82B
| $165M | 0.36% |
2,132,343
-547,637
| -20% | -$42.8M |
|
41
Mastercard
MA
$477B
| $161M | 0.35% |
565,821
-229,224
| -29% | -$76M |
|
42
Annaly Capital Management
NLY
$16.9B
| $160M | 0.35% |
9,353,019
+1,568,135
| +20% | +$39.5M |
|
43
McKesson
MCK
$98.5B
| $160M | 0.35% |
472,124
-202,770
| -30% | -$70.4M |
|
44
Option Care Health
OPCH
$3.4B
| $157M | 0.34% |
5,000,053
+1,066,480
| +27% | +$34.1M |
|
45
Cisco
CSCO
$450B
| $157M | 0.34% |
3,919,178
+1,887,331
| +93% | +$83.7M |
|
|
HZNP
46
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $155M | 0.34% |
2,506,329
+2,347,834
| +1,481% | +$164M |
|
47
BJs Wholesale Club
BJ
$11.9B
| $154M | 0.34% |
2,113,286
+1,308,643
| +163% | +$93.8M |
|
48
Cboe Global Markets
CBOE
$29.8B
| $152M | 0.33% |
1,291,913
+167,373
| +15% | +$20.1M |
|
49
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $148M | 0.33% |
1,447,700
+183,900
| +15% | +$20.7M |
|
|
CNH
50
CNH Industrial
CNH
$13.8B
| $143M | 0.31% |
12,523,401
-2,966,911
| -19% | -$35.7M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.